Meyler's Side Effects of Drugs in Cancer and Immunology

Inbunden, Engelska, 2010

Av Jeffrey K. Aronson, Jeffrey K. (consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust) Aronson, J. K. Aronson

859 kr

Beställningsvara. Skickas inom 7-10 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

Elsevier now offers a series of derivative works based on the acclaimed Meyler's Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing biomedical researcher and/or clinician.

There has been significant progress in the development of targeted therapy drugs that act specifically on certain cancers, and that minimize damage to normal cells. Oncologists and cancer researchers will rely on this volume to determine effective drug treatments.

The only drug guide that includes clinical case studies and expert analysis
UNIQUE! Features not only anticancer drugs, but also all other drugs that act upon related organ systems affected by cancer
Most complete cross referencing of drug-drug interactions available
Latest content from the most highly regarded compilation of drug side effects: Side Effects of Drugs Annual serial

Produktinformation

Utgivningsdatum2010-04-19
Mått216 x 276 x 47 mm
Vikt2 070 g
FormatInbunden
SpråkEngelska
Antal sidor780
FörlagElsevier Science
ISBN9780444532671

Tillhör följande kategorier

Onkologi inom Medicin
Farmakologi inom Medicin

Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK’s National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.